Form 4: UnitedHealth Group CFO Sells Shares in Recent Transaction

UnitedHealth Group's President and CFO, John F. Rex, disposed of 314.585 shares of common stock on November 13, 2024.

Summary

• John F. Rex, President and CFO of UnitedHealth Group, sold 314.585 shares of common stock on November 13, 2024.
• The sale was executed at a price of $605.87 per share.
• Following the transaction, Mr. Rex directly owns 166,109.404 shares of UnitedHealth Group common stock.
• He also indirectly owns 6,791 shares through a trust.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an insider stock sale, which is neither positive nor negative in itself. It is a neutral event.

Industry Context

This is a routine filing related to insider trading activity and is common for executives of publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• Executives at companies like CVS Health, Anthem, and Humana also regularly file similar forms when they trade their company's stock.

Stakeholder Impact

• The stock sale by the CFO may have a minor impact on investor sentiment, but is unlikely to have a significant impact on the company's operations or financial health.

Key Dates

Keywords

UnitedHealth Group, UNH, John F. Rex, CFO, stock sale, insider trading, Form 4, share disposal